Funding Rounds
EverImmune

EverImmune Series A (2021, $5M)

EverImmune

Developer of biotherapeutic products to treat cancer.

View Company Profile

GET THE TOP 10 COMPANIES OF THE WEEK IN YOUR EMAIL, EVERY TUESDAY.

OR DOWNLOAD OUR DATABASE OF 17,000 COMPANIES →

Summary

Stage: Series A

Raised Amount: $5.30M